Congestive Heart Failure: Clinical Trials

31 trials for Congestive Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed. 31 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 331Completed 31
Phase 28Completed 8

Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
OPC-61815 injection - Congestive Heart Failure
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.452019-06-172021-09-05
Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
OPC-61815, Tolvaptan Tab 15 MG - Congestive Heart Failure
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.2942019-01-162021-08-05
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
Albuterol, Saline placebo - Congestive Heart Failure, Heart Failure, Left-Sided
Phase 3CompletedMayo Clinic302016-09-012019-02-22
Sub-Q Versus IV Furosemide in Acute Heart Failure
Furosemide Injection Solution (SCP-101), Furosemide Injection Solution, USP - Congestive Heart Failure
Phase 2 / Phase 3CompletedJohns Hopkins University402016-02-012017-12-18
Blood Pressure Reduction in Heart Failure
Hydralazine/amlodipine, Placebo - Heart Failure, Cardiac Failure
Phase 2 / Phase 3CompletedUniversity of Sao Paulo212011-01-012014-06-10
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
furosemide and hypertonic saline solution, furosemide - Congestive Heart Failure, Renal Insufficiency
Phase 3CompletedAspirus Heart and Vascular Institute-Research and Education502009-11-012012-02-09
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Aliskiren, Placebo - Acute Decompensated Heart Failure, Congestive Heart Failure
Phase 3CompletedNovartis Pharmaceuticals16392009-05-012013-11-07
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
tonapofylline, Placebo - Renal Insufficiency, Congestive Heart Failure
Phase 3CompletedBiogen4202008-07-312023-09-11
Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure
Cardiac resynchronization pacemaker (InSync Sentry or Concerto, Medtronic, Minneapolis, MN,USA) with two intracardiac leads, Triple-site cardiac resynchronization - Congestive Heart Failure, Heart Disease
Phase 2 / Phase 3CompletedSilesian Centre for Heart Diseases1002008-02-012016-04-13
Improving Clinician Communication Skills (ICCS)
Training Program Intervention - Advanced Cancer, Chronic Obstructive Pulmonary Disease (COPD)
Phase 3CompletedUniversity of Washington60862007-04-012014-09-16
Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure
Intramyocardial injection of autologous CD133+ marrow cells - Coronary Artery Disease With Need for Bypass Surgery, Myocardial Ischemia, Angina Pectoris
Phase 2 / Phase 3CompletedGerman Heart Institute602007-04-012013-01-16
An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure
Nesiritide - Heart Decompensation, Congestive Heart Failure
Phase 3CompletedXian-Janssen Pharmaceutical Ltd.412006-10-012014-02-28
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Darbepoetin alfa, Placebo - Heart Failure, Anemia
Phase 3CompletedAmgen22782006-06-012022-11-08
A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure
carvedilol controlled release, carvedilol immediate release - Congestive Heart Failure
Phase 3CompletedCTI-1, LLC3182006-03-012023-03-28
DILIPO (DILutIonal HyPOnatremia)
SR121463B - Congestive Heart Failure
Phase 3CompletedSanofi1502005-05-012008-09-15
APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation
Optimized echo-guided CRT pacing, normal RV pacing - Congestive Heart Failure, Atrial Fibrillation
Phase 3CompletedAzienda USL Reggio Emilia - IRCCS4582005-05-012025-06-12
Continuous Positive Airway Pressure for Acute Pulmonary Edema
Continuous Positive Airway Pressure (CPAP), usual care of acute pulmonary oedema - Pulmonary Edema, Dyspnea
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2082004-10-012010-03-30
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
Tolvaptan - Congestive Heart Failure
Phase 3CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.36002003-09-012012-05-03
Study of Sildenafil in Advanced Heart Failure.
sildenafil - Congestive Heart Failure
Phase 3CompletedMassachusetts General Hospital402003-05-012009-08-11
Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead
EASYTRAK 3 left ventricular pacing lead - Congestive Heart Failure
Phase 2 / Phase 3CompletedBoston Scientific Corporation1152003-05-012007-06-25

Showing 20 of 31. Sign in to see all of them.

Narrower conditions

Heart Failure (31)  ·  Renal Insufficiency (3)  ·  Ventricular Dysfunction (3)  ·  Anemia (1)  ·  Angina Pectoris (1)  ·  Atrial Fibrillation (1)  ·  Cardio-Renal Syndrome (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Dyspnea (1)  ·  End Stage Liver Disease (1)  ·  Heart Diseases (1)  ·  Hypertension, Pulmonary (1)  ·  Hyponatremia (1)  ·  Kidney Diseases (1)

Broader conditions

Cardiovascular Diseases (30)  ·  Heart Diseases (30)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Lung Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Respiratory Tract Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Kidney Diseases (2)  ·  Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Arrhythmias, Cardiac (1)

Interventions

Carvedilol (3)  ·  candesartan (3)  ·  candesartan cilexetil (3)  ·  Furosemide (2)  ·  Natriuretic Peptide, Brain (2)  ·  Sildenafil Citrate (2)  ·  Tolvaptan (2)  ·  1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine (1)  ·  Albuterol (1)  ·  Amlodipine (1)  ·  BG 9928 (1)  ·  Cardiac Resynchronization Therapy (1)  ·  Continuous Positive Airway Pressure (1)  ·  Darbepoetin alfa (1)  ·  Defibrillators (1)

Sponsors

AstraZeneca (3)  ·  Boston Scientific Corporation (3)  ·  Massachusetts General Hospital (2)  ·  Mayo Clinic (2)  ·  Otsuka Pharmaceutical Co., Ltd. (2)  ·  Shaddy, Robert, M.D. (2)  ·  Advanz Pharma (1)  ·  Amgen (1)  ·  Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda USL Reggio Emilia - IRCCS (1)  ·  Biogen (1)  ·  Bristol-Myers Squibb (1)  ·  CTI-1, LLC (1)  ·  German Heart Institute (1)

Countries

United States (18)  ·  Poland (7)  ·  Argentina (6)  ·  Brazil (6)  ·  Canada (6)  ·  France (6)  ·  Germany (6)  ·  Italy (6)  ·  Sweden (6)  ·  Belgium (5)  ·  Czechia (5)  ·  Romania (5)  ·  Russia (5)  ·  Australia (4)  ·  Hungary (4)

Top investigators

Marc J Semigran, MD (2)  ·  Barry A Borlaug, MD (1)  ·  Barry Greenberg, MD (1)  ·  Boris Nasseri, MD (1)  ·  Carlo Menozzi, MD (1)  ·  Chris Granger, MD (1)  ·  Christof Stamm, MD (1)  ·  Daniel Ter-Minassian, MD (1)  ·  Dr Salim Yusuf (1)  ·  Edimar A Bocchi, Prof. (1)  ·  German Larrain, MD (1)  ·  J. Randall Curtis, MD, MPH (1)  ·  Joshua Hare, MD (1)

Results publications

PMID 37366061, PMID 19196892, PMID 25326006, PMID 29431256, PMID 31370950, PMID 33301080, PMID 36632831, PMID 15152059, PMID 16230259, PMID 17384437, PMID 17384438, PMID 17848651, PMID 18279770, PMID 18549913, PMID 18992654, PMID 19001508, PMID 19204305, PMID 20142024, PMID 20231531, PMID 20435194, PMID 21068341, PMID 21123186, PMID 21199833, PMID 21292991, PMID 21350053, PMID 21606084, PMID 21693723, PMID 21715583, PMID 21750125, PMID 21805159, PMID 21875912, PMID 22064591, PMID 22093207, PMID 22267751, PMID 22651239, PMID 22887722, PMID 23351825, PMID 23478743, PMID 23487543, PMID 23743487, PMID 24302090, PMID 24497345, PMID 24626998, PMID 24649963, PMID 24737459, PMID 24864045, PMID 24874200, PMID 25225241, PMID 25319879, PMID 26067854

NIH funding

2009 (1), R01HL126638 (1), R01HL128526 (1), R01NR009987 (1), U01HL125205 (1), U10HL110262 (1)